SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-24-000522
Filing Date
2024-05-22
Accepted
2024-05-22 19:32:01
Documents
2
Group Members
ORBIMED ADVISORS II LTDORBIMED ASIA GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 ss3420608_sc13da.htm SC 13D/A 101039
2 JOINT FILING AGREEMENT ss3420608_ex9901.htm EX-99.1 6366
  Complete submission text file 0000947871-24-000522.txt   109038
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Subject) CIK: 0001944885 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94041 | Film No.: 24974910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)